Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FD4ZE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,926
Award facts
- Contract value 100% obligated
- $96,926.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $96,926.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of October 21, 2025. This delivery order was issued without a set-aside designation and represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The awardee, a woman-owned small business based in Park Ridge, Illinois, specializes in pharmaceutical distribution to federal healthcare facilities and has been registered in the System for Award Management since 2001.
DMS Pharmaceutical Group holds a significant $499,999,999 single-award indefinite delivery contract with the Defense Logistics Agency under the SPE2DB program, valid through November 2026, which serves as the vehicle enabling issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare needs. Stelara is an immunosuppressant biologic therapy commonly used in military and federal healthcare settings for treating autoimmune conditions. As a established pharmaceutical wholesaler focused on supplying branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide, DMS Pharmaceutical Group has demonstrated consistent capability in fulfilling critical pharmaceutical supply requirements across the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FD4ZE?
SPE2DB25FD4ZE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FD4ZE worth?
The government has obligated $96,926 on SPE2DB25FD4ZE.
Is contract SPE2DB25FD4ZE an order under another contract?
Yes. SPE2DB25FD4ZE is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4ZE competed?
The extent of competition for SPE2DB25FD4ZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award